Dona Ferentes
A little bit OC⚡DC
- Joined
- 11 January 2016
- Posts
- 15,068
- Reactions
- 20,435
An occasional log of random ideas, oft provoked by comments from others in threads
Thought Bubble #1
This one has come about along these lines:
1. A contributor to a thread mentioned mentioned he bought into CSL at the float (forget who, but well done!) AND HASN'T SOLD
2. He then raised questions about where/ how to invest now.
3. We're in a time of Capital being raised/ allocated because Covid-19 is changing all the rules
Here goes;
1. Assuming 3,000 CSL picked up for 63c a share = $2K; now with a market value close to $900K. There's a pretty fair whack of CGT if sold, and why would you want to? But a bit of diversification wouldn't go astray. What about a Margin Loan, because the LVR on CSL is >70%. Wouldn't advocate going that high, but say about $400K borrowed, staying under 50% and a suitable buffer. (I'd actually go for less, keeping no more than 30% because Margin Calls are to be avoided at all costs.)
2. On 07 April, the ASX introduced temporary changes to its rules to facilitate emergency capital raisings against the current backdrop of the COVID-19 pandemic including:
3. The reality is that most raised Capital recently has gone through institutions and the retail component is an afterthought, mostly offers of SPP but with upper limits and scale back of applications. Only a few have been pro rata entitlements and even fewer have been renounceable.
4. But there is some upside for most, or at least a put option in the form of the VWAP calculation
5. These capital raises are coming fast and furious.
6. So, why not hold a few hundred companies out of the 2000+ on the ASX and scalp a bit as each comes along. It's not surefire, but I saw similar opportunities line up in GFC and there are quite a few around right now (possibly too late)
7. Of course, a good relationship with a Margin Lender would help, to fund the SPPs as they come along.
8. As noted, many of the Plans are only allocating a percentage of the offer. Sadly most offers contain clauses like this:
Thought Bubble #1
This one has come about along these lines:
1. A contributor to a thread mentioned mentioned he bought into CSL at the float (forget who, but well done!) AND HASN'T SOLD
2. He then raised questions about where/ how to invest now.
3. We're in a time of Capital being raised/ allocated because Covid-19 is changing all the rules
Here goes;
1. Assuming 3,000 CSL picked up for 63c a share = $2K; now with a market value close to $900K. There's a pretty fair whack of CGT if sold, and why would you want to? But a bit of diversification wouldn't go astray. What about a Margin Loan, because the LVR on CSL is >70%. Wouldn't advocate going that high, but say about $400K borrowed, staying under 50% and a suitable buffer. (I'd actually go for less, keeping no more than 30% because Margin Calls are to be avoided at all costs.)
2. On 07 April, the ASX introduced temporary changes to its rules to facilitate emergency capital raisings against the current backdrop of the COVID-19 pandemic including:
- increasing the placement capacity for listed companies to 25% of their share capital, subject to the placement being fully paid ordinary shares and there being a follow-on accelerated pro rata entitlement offer or share purchase plan offer (SPP). Where small or mid-cap companies already have an additional 10% capacity approved under Listing Rule 7.1A, the aggregate maximum remains at 25%, but companies can choose to use the Listing Rule 7.1A capacity or the new increased Listing Rule 7.1 capacity
- waiving Share Purchase Plan requirements for the number of shares issued to be limited to 30% of the issued capital and the issue price to be at least 80% of VWAP which are replaced with a requirement that: for follow on SPPs, the issue price must be equal to or lower than the placement price; and for stand-alone SPPs the issue price may be determined by the Board
- a waiver of the one for one cap on non-renounceable entitlement offers
- permitting back to back trading halts whereby a listed entity may request two consecutive trading halts allowing in total up to four trading days in halt, to consider, plan for and execute a capital raising.
3. The reality is that most raised Capital recently has gone through institutions and the retail component is an afterthought, mostly offers of SPP but with upper limits and scale back of applications. Only a few have been pro rata entitlements and even fewer have been renounceable.
4. But there is some upside for most, or at least a put option in the form of the VWAP calculation
5. These capital raises are coming fast and furious.
6. So, why not hold a few hundred companies out of the 2000+ on the ASX and scalp a bit as each comes along. It's not surefire, but I saw similar opportunities line up in GFC and there are quite a few around right now (possibly too late)
7. Of course, a good relationship with a Margin Lender would help, to fund the SPPs as they come along.
8. As noted, many of the Plans are only allocating a percentage of the offer. Sadly most offers contain clauses like this:
Company reserves the right (in its absolute discretion) to scale-back applications if demand exceeds A$ xxx,000. If the Company chooses to scale back applications it will do so on a pro-rata basis (determined either by the number of shareholders participating, and/or the size of the Eligible Shareholder’s shareholding at the Record Date, and/or the number of shares an Eligible Shareholder has applied for under the SPP).